Delivery Order SPE2DB20D3103-SPE2DB23FN7H6
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zestoretic 20-12.5 mg tablets. The $4,854.06 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to military healthcare programs globally....
- This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90-count bottles of the 20 mg lisinopril tablet. The $2,220.25 firm fixed-price delivery order falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of 40 mg Lisinopril tablets. The contract has a ceiling value of $4,312.22 and runs through February 27, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,053.78 Firm Fixed Price Delivery Order is for the supply of 4564641245 - ZESTORETIC 20-12.5 MG TABLET 90S, with a performance period through May 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.74 to AmerisourceBergen Drug Corp for 90 tablets of Zestoretic 10-12.5 mg, a combination antihypertensive medication. This non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and is structured as a firm fixed-price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,524.03 delivery order contract is for the supply of Lisinopril 20 mg tablets, a cardiovascular medication. The contract has a period of performance through January 20, 2022 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999...
- This is a federal contract award valued at $7,856.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 1,000 units of the medication Lisinopril-HCTZ 10-12.5 mg tablets. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award SPE2DB22D1017|SPE2DB24FF9SQ was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.57 firm fixed-price delivery order is for the supply of 1,000 Lisinopril-HCTZ 20-12.5 mg tablets, with a completion date of June 18, 2024. This award is not part of a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN7H6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,661.08, is a delivery order for the pharmaceutical product Zestril 20 mg Tablet 90s. This award is under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen, as a leading pharmaceutical distributor, plays a critical role in supplying essential medical products to various federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 6/15/23 |